DCGI approves DRDO's anti-COVID drug for emergency use
Published
Published
The Drugs Controller General of India (DGCI) has approved the oral drug for emergency use.
A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General..